PT UBC Medical Indonesia Tbk (IDX:LABS)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
147.00
+1.00 (0.68%)
Mar 3, 2026, 4:00 PM WIB

IDX:LABS Ratios and Metrics

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21
576,700529,300---
Enterprise Value
579,063545,030---
Last Close Price
146.00134.00---
PE Ratio
62.00179.29---
PS Ratio
3.263.59---
PB Ratio
3.833.82---
P/TBV Ratio
3.953.97---
EV/Sales Ratio
3.283.69---
EV/EBITDA Ratio
20.7725.81---
EV/EBIT Ratio
38.8060.88---
Debt / Equity Ratio
0.180.260.840.412.82
Debt / EBITDA Ratio
0.991.682.631.542.31
Net Debt / Equity Ratio
0.02-0.050.770.391.57
Net Debt / EBITDA Ratio
0.09-0.312.451.541.32
Net Debt / FCF Ratio
0.140.32-1.10-1.02-0.45
Asset Turnover
-0.811.020.92-
Inventory Turnover
-1.381.771.70-
Quick Ratio
1.071.180.410.300.23
Current Ratio
2.853.021.230.990.70
Return on Equity (ROE)
-3.14%4.52%10.00%-
Return on Assets (ROA)
-3.08%2.71%2.08%-
Return on Invested Capital (ROIC)
7.77%4.56%2.68%4.73%1.55%
Return on Capital Employed (ROCE)
9.70%5.90%8.30%7.00%28.60%
Earnings Yield
1.61%0.56%---
FCF Yield
2.86%-3.87%---
Buyback Yield / Dilution
-67.78%-67.78%---
Source: S&P Global Market Intelligence. Standard template. Financial Sources.